Market Tracker

07/28 5:16pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
9.42 +0.29 / +3.18%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
9.42 +0.0019 / +0.02%
 
Volume: 11.1K

Today’s Trading

Previous close9.13
Today’s open10.87
Day’s range9.07 - 11.15
Volume4,416,549
Average volume (3 months)1,355,591
Market cap$635.9M
Dividend yield--
Data as of 3:59pm ET, 07/28/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-950.00%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+464.45%
P/E ratio189.2
Price/Sales11.63
Price/Book5.09

Competitors

 Today’s
change
Today’s
% change
OMEDOncoMed Pharmaceutic...+0.40+1.93%
OTICOtonomy Inc+0.30+1.11%
OMEROmeros Corp-0.04-0.24%
DERMDermira Inc+0.05+0.21%
Data as of 3:59pm ET, 07/28/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$44.4M
Annual profit (last year)$4.4M
Net profit margin9.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
CFO, Treasurer, Principal Accounting Officer &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts